About Coherex
Coherex is a Healthcare company based in Salt Lake City (United States) founded in 2003, and was acquired by Biosense Webster in November 2015. It operates as a structural heart disease conditions are addressed with implant devices. Coherex has raised $25.03 million across 2 funding rounds from investors including BioSense Webster, Tullis Health Investors and Signal Peak. The company has 19 employees. The company was acqui-hired. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is COHEREX MEDICAL, INC. Its competitors include PECA Labs, Xeltis, Occlutech, Endonovo Therapeutics and AdvancedCPR Solutions and 3 more; 5 of its 8 listed competitors have raised funding.
Company details
Medical devices for structural heart disease were developed by Coherex Medical, Inc., founded as Proximare, Inc. in 2003 and renamed in 2006. A patent foramen ovale closure system was created to promote tissue in-growth for sustained closure. Operations focused on cardiovascular implants in the medtech sector. The company, based in Salt Lake City, United States, was acquired by Johnson Johnsons Biosense Webster in November 2015.
- Headquarters Salt Lake City, United States
- Employees 19
- Stage Acquired
- SectorsHealthcare
- Website coherex.com
- Social LinkedIn
- Acquired by Biosense Webster (Nov 2015)
- Legal Name Coherex Medical, Inc.
- Total Equity Funding$25.03M (USD)
in 2 rounds
- Latest Funding Round$16.5M (USD), Series B
Aug 2009
- InvestorsBioSense Webster
& 3 more
- Employee Count19
- Acquired byBiosense Webster
(Nov 2015)
Funding Insights of Coherex
Coherex has successfully raised a total of $25.03M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $16.5 million completed in August 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $25.03M
- Total Rounds 2
- Last Round Series B — $16.5M
- First Round $8.53M
(Apr 2007)
- Investors Count 3
All 2 funding rounds of Coherex with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2009 | $16.5M | Series B | – | – | |
| Apr 2007 | $8.53M | Series A | – | – |
4 investors in total: 4 institutional.
Investors in Coherex
Coherex has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include BioSense Webster, Tullis Health Investors and Signal Peak.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare investments are made by Tullis Health Investors. | – | tullisfunds.com | Palm Beach Gardens, United States | |
Early-stage investments in US tech and life sciences are targeted. | – | spv.com | Salt Lake City, United States | |
Early stage VC firm investing in the US and Korea | – | oxbio.com | Boston, United States | |
Solutions to treat Cardiac Arrythmia | 1970 | biosensewebster.com | Diamond Bar, United States |
Investor details for Coherex
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Coherex
4 dated milestones of Coherex across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Coherex is founded.
- Funding First funding round of $8.5M.
- Funding Latest funding round, Series B, of $16.5M.
- Exit Acquired by Biosense Webster.
Competitors of Coherex
Coherex has 8 listed competitors in our database, 5 of them funded. They include PECA Labs, Xeltis, Occlutech, Endonovo Therapeutics and AdvancedCPR Solutions, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pecalabs.com | 2011 | Pittsburgh, United States | $19.91M | – | Pediatric cardiac surgical devices are developed for congenital heart defects. | |
| xeltis.com | 2006 | Zurich, Switzerland | $164.42M | – | Developer of bioabsorbable synthetic heart valves and vascular grafts | |
| occlutech.com | 2003 | Schaffhausen, Switzerland | $70.81M | – | Provider of minimally invasive cardiac devices for congenital heart defects, stroke prevention and heart failure | |
| endonovo.com | 2011 | Los Angeles, United States | – | – | Bioelectronic devices are developed for regenerative medicine therapies. | |
| elevatedcpr.com | 2015 | Edina, United States | $9.51M | – | CPR products for sudden cardiac arrest treatment are developed. | |
| coaptus.com | 2003 | Redmond, United States | $3M | 40 | Develops non-implant therapeutics for treating patent foramen ovale, a structural heart defect. | |
| amplatzer.com | 1995 | Plymouth, United States | – | – | Devices to treat congenital heart diseases and peripheral vascular diseases | |
| mallowmedical.com | 2003 | Xuhui, China | – | – | Medical devices for congenital heart defects are developed and offered. |
Detailed competitors of Coherex
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
10 companies that operate in the same segment as Coherex (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | – | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Coherex
Coherex was founded in 2003 and raised its 1st funding round 4 years after it was founded.
Coherex is headquartered in Salt Lake City, United States. It is registered at Salt Lake City, Utah, United States.
Coherex is a funded company, having raised a total of $25.03M across 2 funding rounds to date. The company's 1st funding round was a Series A of $8.53M, raised on Apr 2007.
Coherex has 19 employees.
Medical devices for structural heart disease were developed by Coherex Medical, Inc., founded as Proximare, Inc. in 2003 and renamed in 2006. A patent foramen ovale closure system was created to promote tissue in-growth for sustained closure. Operations focused on cardiovascular implants in the medtech sector. The company, based in Salt Lake City, United States, was acquired by Johnson Johnsons Biosense Webster in November 2015.
Coherex's top competitors include Xeltis, PECA Labs and Endonovo Therapeutics.
Coherex has 4 investors. Key investors include BioSense Webster, Tullis Health Investors, Signal Peak, and Oxford Bioscience Partners.
Coherex operates through Coherex Medical, Inc..
Yes. Coherex was acquired by Biosense Webster in November 2015.